These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 20547787)

  • 1. Aerosol therapy with colistin methanesulfonate: a biopharmaceutical issue illustrated in rats.
    Marchand S; Gobin P; Brillault J; Baptista S; Adier C; Olivier JC; Mimoz O; Couet W
    Antimicrob Agents Chemother; 2010 Sep; 54(9):3702-7. PubMed ID: 20547787
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substantial Targeting Advantage Achieved by Pulmonary Administration of Colistin Methanesulfonate in a Large-Animal Model.
    Landersdorfer CB; Nguyen TH; Lieu LT; Nguyen G; Bischof RJ; Meeusen EN; Li J; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27821445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of intrapulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and colistin after aerosol delivery and intravenous administration of CMS in critically ill patients.
    Boisson M; Jacobs M; Grégoire N; Gobin P; Marchand S; Couet W; Mimoz O
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7331-9. PubMed ID: 25267660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Population pharmacokinetics of colistin methanesulfonate in rats: achieving sustained lung concentrations of colistin for targeting respiratory infections.
    Yapa SWS; Li J; Porter CJ; Nation RL; Patel K; McIntosh MP
    Antimicrob Agents Chemother; 2013 Oct; 57(10):5087-95. PubMed ID: 23917323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of nebulized colistin methanesulfonate in critically ill patients.
    Boisson M; Grégoire N; Cormier M; Gobin P; Marchand S; Couet W; Mimoz O
    J Antimicrob Chemother; 2017 Sep; 72(9):2607-2612. PubMed ID: 28575278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dose-ranging pharmacokinetics of colistin methanesulphonate (CMS) and colistin in rats following single intravenous CMS doses.
    Marchand S; Lamarche I; Gobin P; Couet W
    J Antimicrob Chemother; 2010 Aug; 65(8):1753-8. PubMed ID: 20507861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assay of colistin and colistin methanesulfonate in plasma and urine by liquid chromatography-tandem mass spectrometry.
    Gobin P; Lemaître F; Marchand S; Couet W; Olivier JC
    Antimicrob Agents Chemother; 2010 May; 54(5):1941-8. PubMed ID: 20176909
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of Colistin Methansulphonate (CMS) and Colistin after CMS Nebulisation in Baboon Monkeys.
    Marchand S; Bouchene S; de Monte M; Guilleminault L; Montharu J; Cabrera M; Grégoire N; Gobin P; Diot P; Couet W; Vecellio L
    Pharm Res; 2015 Oct; 32(10):3403-14. PubMed ID: 26040660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biopharmaceutical characterization of nebulized antimicrobial agents in rats: 2. Colistin.
    Gontijo AV; Grégoire N; Lamarche I; Gobin P; Couet W; Marchand S
    Antimicrob Agents Chemother; 2014 Jul; 58(7):3950-6. PubMed ID: 24798284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats.
    Lin YW; Zhou QT; Hu Y; Onufrak NJ; Sun S; Wang J; Forrest A; Chan HK; Li J
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28807905
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New colistin population pharmacokinetic data in critically ill patients suggesting an alternative loading dose rationale.
    Grégoire N; Mimoz O; Mégarbane B; Comets E; Chatelier D; Lasocki S; Gauzit R; Balayn D; Gobin P; Marchand S; Couet W
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7324-30. PubMed ID: 25267662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary and systemic pharmacokinetics of inhaled and intravenous colistin methanesulfonate in cystic fibrosis patients: targeting advantage of inhalational administration.
    Yapa SWS; Li J; Patel K; Wilson JW; Dooley MJ; George J; Clark D; Poole S; Williams E; Porter CJ; Nation RL; McIntosh MP
    Antimicrob Agents Chemother; 2014 May; 58(5):2570-9. PubMed ID: 24550334
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of colistin after nebulization or intravenous administration of colistin methanesulphonate (Colimycin®) to cystic fibrosis patients.
    Magréault S; Mankikian J; Marchand S; Diot P; Couet W; Flament T; Grégoire N
    J Cyst Fibros; 2020 May; 19(3):421-426. PubMed ID: 31501050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Population pharmacokinetic analysis of colistin methanesulfonate and colistin after intravenous administration in critically ill patients with infections caused by gram-negative bacteria.
    Plachouras D; Karvanen M; Friberg LE; Papadomichelakis E; Antoniadou A; Tsangaris I; Karaiskos I; Poulakou G; Kontopidou F; Armaganidis A; Cars O; Giamarellou H
    Antimicrob Agents Chemother; 2009 Aug; 53(8):3430-6. PubMed ID: 19433570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Population pharmacokinetic analysis of colistin in burn patients.
    Lee J; Han S; Jeon S; Hong T; Song W; Woo H; Yim DS
    Antimicrob Agents Chemother; 2013 May; 57(5):2141-6. PubMed ID: 23439640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary and systemic pharmacokinetics of colistin methanesulfonate (CMS) and formed colistin following nebulisation of CMS among patients with ventilator-associated pneumonia.
    Gkoufa A; Sou T; Karaiskos I; Routsi C; Lin YW; Psichogiou M; Zakynthinos S; Giamarellou H; Li J; Friberg LE
    Int J Antimicrob Agents; 2022 Jun; 59(6):106588. PubMed ID: 35405269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of colistin methanesulphonate and colistin in rats following an intravenous dose of colistin methanesulphonate.
    Li J; Milne RW; Nation RL; Turnidge JD; Smeaton TC; Coulthard K
    J Antimicrob Chemother; 2004 May; 53(5):837-40. PubMed ID: 15044428
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and pharmacokinetic evaluation of intravenous colistin methanesulfonate sodium in Japanese healthy male subjects.
    Mizuyachi K; Hara K; Wakamatsu A; Nohda S; Hirama T
    Curr Med Res Opin; 2011 Dec; 27(12):2261-70. PubMed ID: 21995648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of diluent volume of colistimethate sodium on aerosol characteristics and pharmacokinetics in ventilator-associated pneumonia caused by MDR bacteria.
    Bihan K; Zahr N; Becquemin MH; Lu X; Bertholon JF; Vezinet C; Arbelot C; Monsel A; Rouby JJ; Langeron O; Lu Q
    J Antimicrob Chemother; 2018 Jun; 73(6):1639-1646. PubMed ID: 29506194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biopharmaceutical Characterization of Nebulized Antimicrobial Agents in Rats: 3. Tobramycin.
    Marchand S; Grégoire N; Brillault J; Lamarche I; Gobin P; Couet W
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6646-7. PubMed ID: 26239992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.